Renal Cancer Drugs Market by Type (Clear Cell, Papillary, Chromophobe, Oncocytic, Collecting Duct), Brand (Sutent, Nexavar, Afinitor, Votrient, Inlyta, Avastin, Torisel, Proleukin) - Analysis and Global Forecast to 2019

-
Renal Cancer Drug Market
Renal cancer commonly known as kidney cancer originates in the lining of the proximal convoluted tubule of the kidney. The renal cancer is caused by Von Hippel-Lindau (VHL) syndrome, obesity, smoking, high blood pressure, long-term dialysis, occupational exposure (for example asbestos workers). The symptoms of renal cancer include a lump or mass in the abdomen or side, blood in the urine, weight loss, fever, and lethargy. Several drugs for the treatment of renal cancer are currently available in the market.
The global renal cancer drug market is likely to show significant growth during the forecast period. This is attributed to the rising incidences of renal cancer, increasing geriatric population, and approval of novel molecules to develop drugs. However, high prices of branded drugs to treat cancer and rising preference for generic drugs are expected to restrain the market for renal cancer drugs market.
Categories of Renal Cancer Drugs 
The renal cancer drugs market is segmented into three broad categories: by type, by brand, and by geography. Based on type, the market is divided into clear cell, papillary (Types 1 and 2), chromophobe, oncocytic, and collecting duct. The renal cancer drugs market, by brand is categorized into Sutent (Sunitinib), Nexavar (Sorafenib), Afinitor (Everolimus), Votrient (Pazopanib), Inlyta (Axitinib), Avastin (Bevacizumab), Torisel (Temsirolimus), Proleukin (Aldesleukin), and others.
Geographically Region
The global renal cancer drugs market is segmented into North America, Europe, Asia and Rest of the World (RoW: Latin America, Pacific Countries, and Middle East & Africa). North America accounted for the largest share of global renal cancer drugs, by region in 2014. However, Asia is expected to be the fastest growing market during the forecast period.
Key Players
Some of the major players in the global renal cancer drugs market include Active Biotech AB (Sweden), Amgen (U.S.), Bayer AG (Germany), Cipla Limited (India), F. Hoffmann-La Roche AG (Switzerland), Genentech, Inc. (U.S.), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Onyx Pharmaceuticals Inc. (U.S.), Pfizer, Inc. (U.S.).
To know about the assumptions considered for the study, download the pdf brochure
Location: United States

Comments

Post a Comment

If you have any issue, Let me know ?

Popular posts from this blog

Laboratory Balances and Scales Market by Product (Balances (Analytical, Precision, Micro, Portable, Moisture) - Global Forecast to 2023

-
Image
According to the new market research report  " Laboratory Balances and Scales Market  by Product (Balances (Analytical, Precision, Micro, Portable, Moisture), Scales (Bench, Counting, Compact)), End User (Pharmaceutical, Biotechnology, Chemical, Beverage, Petroleum, Academia) - Global Forecast to 2023" , published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW). The major factors driving the growth of the laboratory balances and scales market are the technological advancements in laboratory balances and scales; increasing research investments and activities among pharma-biotech companies and CROs; increasingly stringent regulatory framework for product safety in bio-pharmaceutical industries; implementation of stringent food safety guidelines; and emerging markets. Based on product type, the laboratory balances market is segmented into m...
Read more

New Approach towards Technological Advancements in Ligation Devices Market

-
Growth in this market is mainly driven by the increasing prevalence of diseases requiring surgical treatment, especially minimally invasive surgery (MIS). However, the high cost of ligation devices is a major restraint for this market, particularly in emerging countries. Ligation Devices Market Growth The  Global ligation devices market  is projected to reach $1,189 million by 2024 from $876 million in 2019, at a CAGR of 6.3%. Download PDF Brochures –  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=22007372 Accessories – Ligation Devices The market is segmented into handheld instruments and accessories. The accessories segment accounted for a share of 68.2% in 2018 and is anticipated to grow at a CAGR of 6.9% during the forecast period. This growth can be attributed to the increasing number of surgical procedures, especially in emerging markets. Applications – Ligation Devices The market is segmented into gastrointestinal & abdominal surgeries...
Read more

Medical Holography Market is Future of Healthcare, it is Creating Real Change in the Healthcare Industry

-
According to a new market research report “ Medical Holography Market  by Product (Holographic Display, Microscope, Print, Software), Application (Medical Imaging, Medical Education, Biomedical Research), End User (Medical Schools, Pharmaceutical Companies, Hospitals) – Global Forecast to 2021 ” published by MarketsandMarkets, The Global Medical Holography Market Is Projected to Reach USD 953.9 Million by 2021, at a CAGR of 33.7% from 2016 to 2021. The growth in this market can be mainly attributed to the growing clinical applications of holography in the healthcare sector, rising adoption of holography products in biomedical research and medical education, and emergence of holography as a promising technology in representing complex 3D structures. In this report, the global Medical Holography Market is segmented on the basis of product type, application, end user, and region. Based on product type, the market is segmented into holographic displays, holography microscopes, holo...
Read more